Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
55
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Good local tumor control but lethal hemorrhage after apatinib treatment for intractable squamous carcinoma of the floor of the mouth: a case report

Xiaopeng Zhu1 Department of Radiation Oncology, The First Hospital, Jilin University, Changchun 130021, China, [email protected]; [email protected]
,
Min Liu1 Department of Radiation Oncology, The First Hospital, Jilin University, Changchun 130021, China, [email protected]; [email protected]
,
Jincai Lv1 Department of Radiation Oncology, The First Hospital, Jilin University, Changchun 130021, China, [email protected]; [email protected]
,
Liang Guo2 Department of Pathology, The First Hospital, Jilin University, Changchun 130021, China
,
Cheng Li1 Department of Radiation Oncology, The First Hospital, Jilin University, Changchun 130021, China, [email protected]; [email protected]
,
Lihua Dong1 Department of Radiation Oncology, The First Hospital, Jilin University, Changchun 130021, China, [email protected]; [email protected]Correspondence[email protected] [email protected]
&
Bailong Liu1 Department of Radiation Oncology, The First Hospital, Jilin University, Changchun 130021, China, [email protected]; [email protected]Correspondence[email protected] [email protected]
 show all
Pages 8909-8913 | Published online: 07 Dec 2018

References

  • SaggiSBadranKWHanAYKuanECSt JohnMAClinicopathologic characteristics and survival outcomes in floor of mouth squamous cell carcinoma: a population-based studyOtolaryngol Head Neck Surg20181591515829436280
  • FunkGFKarnellLHRobinsonRAZhenWKTraskDKHoffmanHTPresentation, treatment, and outcome of oral cavity cancer: a national cancer data base reportHead Neck200224216518011891947
  • LiRFakhryCKochWMGourinCGThe Effect of tumor subsite on short-term outcomes and costs of care after oral cancer surgeryLaryngoscope201312371652165923686386
  • BancroftCCChenZYehJEffects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma linesInt J Cancer200299453854811992543
  • NibuKIHayashiRAsakageTJapanese clinical practice guideline for head and neck cancerAuris Nasus Larynx201744437538028325607
  • SeiwertTYFayetteJCupissolDA randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neckAnn Oncol20142591813182024928832
  • MachielsJPHaddadRIFayetteJAfatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trialLancet Oncol201516558359425892145
  • FerrisRLBlumenscheinGFayetteJNivolumab for recurrent squamous-cell carcinoma of the head and neckN Engl J Med2016375191856186727718784
  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
  • LüHMZhangMWNiuLMZengHAYanMClinical observation of apatinib mesylate for the treatment of multi-drug resistant advanced breast cancerZhonghua Yi Xue Za Zhi201898161246124929747313
  • LiangWu DNieLLEfficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLCAsia Pac J Clin Oncol Epub2018324
  • LiangLWangLZhuPA pilot study of apatinib as third-line treatment in patients with heavily treated metastatic colorectal cancerClin Colorectal Cancer2018173e443e44929576426
  • LiLXiaoSZhangLAn open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphomaOncotarget2018922162131621929662638
  • XieLGuoWWangYYanTJiTXuJApatinib for advanced sarcoma: results from multiple institutions’ off-label use in ChinaBMC Cancer201818139629625604
  • ZhuBLiJXieQDiaoLGaiLYangWEfficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: an observational studyCancer Biol Ther201819319820429261005
  • MiaoMDengGLuoSA phase II study of apatinib in patients with recurrent epithelial ovarian cancerGynecol Oncol2018148228629029248198
  • WuHLuXXuJA pilot trial assessing apatinib in advanced head and neck squamous cell carcinoma that failed in previous standard chemotherapy or chemoradiotherapyInt J Radiat Oncol Biol Phys20181023e369
  • WuHLuXXuJApatinib plus radiation therapy or not in chemotherapy-refractory recurrent or metastatic oral squamous cell carcinoma: a pilot studyInt J Radiat Oncol Biol Phys20181023e358
  • WangWZhangLXieYZhenTSuGZangQFatal hemoptysis in patients with advanced esophageal cancer treated with apatinibOnco Targets Ther2018112565257029765235

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.